Oral fluid testing: promises and pitfalls
Mostra el registre complet Registre parcial de l'ítem
- dc.contributor.author Huestis, Marylin A.
- dc.contributor.author Verstraete, Alain
- dc.contributor.author Kwong, Tai C.
- dc.contributor.author Morland, Jorg
- dc.contributor.author Vincent, Michael J.
- dc.contributor.author Torre Fornell, Rafael de la
- dc.date.accessioned 2019-02-18T12:00:56Z
- dc.date.available 2019-02-18T12:00:56Z
- dc.date.issued 2011
- dc.description.abstract Oral fluid is a promising new matrix for drug-testing programs for drug treatment, the workplace, pain management, and driving under the influence of drugs (DUID)7. As with any new technology, there are strengths and limitations. We discuss with international experts the role this new alternative matrix will play in diverse drug-monitoring settings, and the research, development, and legislation needed to permit oral fluid testing to best take its place in the modern laboratory armamentarium.
- dc.format.mimetype application/pdf
- dc.identifier.citation Huestis MA, Verstraete A, Kwong TC, Morland J, Vincent MJ, de la Torre R. Oral fluid testing: promises and pitfalls. Clin Chem. 2011 Jun;57(6):805-10. DOI: 10.1373/clinchem.2010.152124
- dc.identifier.doi http://dx.doi.org/10.1373/clinchem.2010.152124
- dc.identifier.issn 0009-9147
- dc.identifier.uri http://hdl.handle.net/10230/36614
- dc.language.iso eng
- dc.publisher American Association for Clinical Chemistry
- dc.relation.ispartof Clinical Chemistry. 2011 Jun;57(6):805-10
- dc.rights © 2016 American Association for Clinical Chemistry
- dc.rights.accessRights info:eu-repo/semantics/openAccess
- dc.subject.other Saliva
- dc.subject.other Abús de substàncies
- dc.subject.other Drogues -- Control
- dc.title Oral fluid testing: promises and pitfalls
- dc.type info:eu-repo/semantics/article
- dc.type.version info:eu-repo/semantics/acceptedVersion